Feb 6 | News
Xceleron, a company involved in accelerating drug development using ultra-sensitive bioanalytical analyses, today announced that existing investors Albion Ventures and Solon Ventures have invested $2.4MM to locate all of the company’s business in its custom-built facility in Germantown, MD which is expected to be fully operational by 31st March 2012.
|
Feb 2 | News
Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand.
|
Jan 31 | News
BOSTON (AP) — Pharmaceutical research contractor Parexel International Corp. said Monday its profit fell 23 percent in the fiscal second quarter due to restructuring charges.
|
Jan 19 | News
Patheon and PROCAPS S.A. have announced an agreement to provide the pharmaceutical industry with a line of prescription pharmaceutical soft-gel product development and manufacturing services.
|
Jan 17 | News
AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has appointed Eduardo Uribe to senior director of quality services at the company's Charleston, SC parenteral manufacturing facility.
|
Jan 17 | News
MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3.
|
Jan 17 | News
PAREXEL Consulting, a business unit of PAREXEL International, a global consultancy serving the biopharmaceutical and medical device industries, today announced that David Elder, formerly a senior official of the U.S. Food and Drug Administration (FDA), has been appointed as a Vice President to its Strategic Compliance Services team.
|
Jan 9 | News
Sigma-Aldrich Corporation has signed an agreement to acquire BioReliance Holdings, Inc., a provider of global biopharmaceutical testing services, from Avista Capital Partners for $350 million in cash. The acquisition is subject to customary closing conditions, including regulatory clearance, and is expected to close in the first quarter of 2012.
|
Jan 4 | News
AAIPharma Services Corp., a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services, a division of Celsis International Ltd. that performs material testing services for the pharmaceutical, biotechnology and manufacturing sectors.
|
Dec 20 2011 | News
Warnex Inc. has entered into a binding agreement with a private company to sell its wholly-owned Analytical Services division, which provides pharmaceutical and biotechnology companies with a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies.
|